Picture of Mauna Kea Technologies SA logo

ALMKT — Mauna Kea Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Mauna Kea Technologies Q2 Sales At EUR 2.68 Million

July 20 (Reuters) - Mauna Kea Technologies SAS
 MKEA.PA :
    * MAUNA KEA TECHNOLOGIES REPORTS SECOND QUARTER AND FIRST
HALF
2023 REVENUE
    * MAUNA KEA TECHNOLOGIES SAS Q2 SALES EUR 2.68 MILLION
    * REVENUE UP 77% IN Q2 2023DRIVEN BY U.S. SALES GROWTH AND
LICENSING FEE INCOME FROM J.V. WITH TASLY PHARMACEUTICAL
    * IN FIRST HALF OF 2023, TOTAL SALES REACHED EUR 6,848K, UP
+102%
VERSUS PRIOR YEAR
    * WE ARE EXPLORING AN EXPANDING NUMBER OF STRATEGIC
PARTNERSHIP
OPPORTUNITIES, WHERE WE SEE POTENTIAL TO ACCELERATE ADOPTION OF
CELLVIZIO IN NOVEL INDICATIONS

Source text for Eikon:  ID:nBw2TmkD2a 
Further company coverage:  MKEA.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Mauna Kea Technologies SA

See all news